诺和诺德公司制定了一个针对肥胖人群采用利拉鲁肽进行干预的三期项目规划，期待着结果的公布。
Novo has a whole three-phase program regarding obesity and liraglutide now, and we are waiting for the results we will see.
诺和诺德公司制定了一个针对肥胖人群采用利拉鲁肽进行干预的三期项目规划，期待着结果的公布。
Novo has a whole three-phase program regarding obesity and liraglutide now, and we are waiting for the results we will see.
应用推荐